AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+29.93%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.38B
AUM Growth
+$2.38B
(-39%)
Cap. Flow
-$2.22B
Cap. Flow
% of AUM
-93.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
109
New
–
Increased
–
Reduced
2
Closed
107
Top Buys
No buys this quarter
Top Sells
| 1 |
CAVA Group
CAVA
|
$743M |
| 2 |
Scholar Rock
SRRK
|
$93.8M |
| 3 |
Kymera Therapeutics
KYMR
|
$89.7M |
| 4 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$86.1M |
| 5 |
Arrowhead Research
ARWR
|
$82.9M |
Sector Composition
| 1 | Consumer Discretionary | 91.02% |
| 2 | Healthcare | 8.98% |
| 3 | Communication Services | 0% |
| 4 | Real Estate | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
dLocal
DLO
$4.09B
| – | – |
-10,482
| Closed | -$84.8K |
|
27
Denali Therapeutics
DNLI
$2.24B
| – | – |
-502,899
| Closed | -$11.7M |
|
28
Dynatrace
DT
$15.1B
| – | – |
-109,000
| Closed | -$4.88M |
|
29
Dyne Therapeutics
DYN
$1.92B
| – | – |
-1,516,960
| Closed | -$53.5M |
|
30
New Oriental
EDU
$7.98B
| – | – |
-12,500
| Closed | -$972K |
|
|
ELEV
31
DELISTED
Elevation Oncology
ELEV
| – | – |
-1,013,015
| Closed | -$2.74M |
|
32
Erasca
ERAS
$406M
| – | – |
-9,630,810
| Closed | -$22.7M |
|
33
Edgewise Therapeutics
EWTX
$1.54B
| – | – |
-811,718
| Closed | -$14.6M |
|
34
Fate Therapeutics
FATE
$115M
| – | – |
-1,032,500
| Closed | -$3.39M |
|
35
Foghorn Therapeutics
FHTX
$298M
| – | – |
-720,720
| Closed | -$4.14M |
|
36
JFrog
FROG
$5.58B
| – | – |
-25,000
| Closed | -$939K |
|
37
Generation Bio
GBIO
$40.3M
| – | – |
-2,830,591
| Closed | -$7.98M |
|
|
CBIO
38
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| – | – |
-8,589,064
| Closed | -$2.42M |
|
39
Alphabet (Google) Class A
GOOGL
$2.79T
| – | – |
-7,000
| Closed | -$1.28M |
|
40
Gossamer Bio
GOSS
$587M
| – | – |
-13,308,968
| Closed | -$12M |
|
|
HOOK
41
DELISTED
HOOKIPA Pharma
HOOK
| – | – |
-5,666,410
| Closed | -$3.35M |
|
|
IGMS
42
DELISTED
IGM Biosciences
IGMS
| – | – |
-3,330,422
| Closed | -$22.9M |
|
43
Intel
INTC
$105B
| – | – |
-25,000
| Closed | -$774K |
|
44
Intapp
INTA
$3.63B
| – | – |
-13,000
| Closed | -$477K |
|
45
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-1,011,500
| Closed | -$8.11M |
|
46
Ironwood Pharmaceuticals
IRWD
$201M
| – | – |
-110,532
| Closed | -$721K |
|
47
Janux Therapeutics
JANX
$1.38B
| – | – |
-203,000
| Closed | -$8.5M |
|
|
KRON
48
DELISTED
Kronos Bio
KRON
| – | – |
-842,954
| Closed | -$1.05M |
|
49
Korro Bio
KRRO
$245M
| – | – |
-413,072
| Closed | -$14M |
|
50
Kura Oncology
KURA
$732M
| – | – |
-1,819,884
| Closed | -$37.5M |
|